Generally rare but occasionally severe weight gain after switching to an integrase inhibitor in virally suppressed AGEhIV cohort participants.

<h4>Objectives</h4>Recent studies have reported disproportionate weight gain associated with integrase strand transfer inhibitor (INSTI) initiation in antiretroviral therapy(ART)-naive people with HIV (PWH), particularly among black women. We investigated if HIV-positive AGEhIV participa...

Full description

Saved in:
Bibliographic Details
Main Authors: Sebastiaan O Verboeket, Anders Boyd, Ferdinand W Wit, Eveline Verheij, Maarten F Schim van der Loeff, Neeltje Kootstra, Marc van der Valk, Peter Reiss, AGEhIV Cohort Study Group
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2021-01-01
Series:PLoS ONE
Online Access:https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0251205&type=printable
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850181682301239296
author Sebastiaan O Verboeket
Anders Boyd
Ferdinand W Wit
Eveline Verheij
Maarten F Schim van der Loeff
Neeltje Kootstra
Marc van der Valk
Peter Reiss
AGEhIV Cohort Study Group
author_facet Sebastiaan O Verboeket
Anders Boyd
Ferdinand W Wit
Eveline Verheij
Maarten F Schim van der Loeff
Neeltje Kootstra
Marc van der Valk
Peter Reiss
AGEhIV Cohort Study Group
author_sort Sebastiaan O Verboeket
collection DOAJ
description <h4>Objectives</h4>Recent studies have reported disproportionate weight gain associated with integrase strand transfer inhibitor (INSTI) initiation in antiretroviral therapy(ART)-naive people with HIV (PWH), particularly among black women. We investigated if HIV-positive AGEhIV participants with suppressed viremia switching to INSTI-containing ART experienced more weight gain compared to HIV-positive virally-suppressed non-switching and HIV-negative controls.<h4>Methods</h4>In the AGEhIV cohort, standardized weight measurements were performed biennially. Participants switching to INSTI-containing ART were 1:2:2 propensity score-matched with controls by age, gender, ethnicity and body mass index. Mean weight changes and proportions experiencing >5% or >10% weight gain were compared between study-groups using linear mixed-effects models and logistic regression, respectively.<h4>Results</h4>121 INSTI-switching participants and 242 participants from each of the control groups were selected. Across groups, median age was 53-55 years, 83-91% were male and 88-93% white. Mean weight change after switch among INSTI-switching participants was +0.14 kg/year (95%CI -0.25, +0.54) and similar among HIV-positive [+0.13 kg/year (95%CI +0.07, +0.33; P = .9)] and HIV-negative [+0.18 kg/year (95%CI 0.00, +0.37; P = .9)] controls. Weight gain >5% occurred in 28 (23.1%) INSTI-switching, 38 HIV-positive (15.7%, P = .085) and 32 HIV-negative controls (13.2%, P = .018). Weight gain >10% was rare.<h4>Conclusions</h4>Switching to INSTI-containing ART in our cohort of predominantly white men on long-term ART was not associated with greater mean weight gain, but >5% weight gain was more common than in controls. These results suggest that not all, but only certain, PWH may be particularly prone to gain a clinically significant amount of weight as a result of switching to INSTI.
format Article
id doaj-art-cdffdeb662f844fca0e9beff1679a8e2
institution OA Journals
issn 1932-6203
language English
publishDate 2021-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj-art-cdffdeb662f844fca0e9beff1679a8e22025-08-20T02:17:50ZengPublic Library of Science (PLoS)PLoS ONE1932-62032021-01-01165e025120510.1371/journal.pone.0251205Generally rare but occasionally severe weight gain after switching to an integrase inhibitor in virally suppressed AGEhIV cohort participants.Sebastiaan O VerboeketAnders BoydFerdinand W WitEveline VerheijMaarten F Schim van der LoeffNeeltje KootstraMarc van der ValkPeter ReissAGEhIV Cohort Study Group<h4>Objectives</h4>Recent studies have reported disproportionate weight gain associated with integrase strand transfer inhibitor (INSTI) initiation in antiretroviral therapy(ART)-naive people with HIV (PWH), particularly among black women. We investigated if HIV-positive AGEhIV participants with suppressed viremia switching to INSTI-containing ART experienced more weight gain compared to HIV-positive virally-suppressed non-switching and HIV-negative controls.<h4>Methods</h4>In the AGEhIV cohort, standardized weight measurements were performed biennially. Participants switching to INSTI-containing ART were 1:2:2 propensity score-matched with controls by age, gender, ethnicity and body mass index. Mean weight changes and proportions experiencing >5% or >10% weight gain were compared between study-groups using linear mixed-effects models and logistic regression, respectively.<h4>Results</h4>121 INSTI-switching participants and 242 participants from each of the control groups were selected. Across groups, median age was 53-55 years, 83-91% were male and 88-93% white. Mean weight change after switch among INSTI-switching participants was +0.14 kg/year (95%CI -0.25, +0.54) and similar among HIV-positive [+0.13 kg/year (95%CI +0.07, +0.33; P = .9)] and HIV-negative [+0.18 kg/year (95%CI 0.00, +0.37; P = .9)] controls. Weight gain >5% occurred in 28 (23.1%) INSTI-switching, 38 HIV-positive (15.7%, P = .085) and 32 HIV-negative controls (13.2%, P = .018). Weight gain >10% was rare.<h4>Conclusions</h4>Switching to INSTI-containing ART in our cohort of predominantly white men on long-term ART was not associated with greater mean weight gain, but >5% weight gain was more common than in controls. These results suggest that not all, but only certain, PWH may be particularly prone to gain a clinically significant amount of weight as a result of switching to INSTI.https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0251205&type=printable
spellingShingle Sebastiaan O Verboeket
Anders Boyd
Ferdinand W Wit
Eveline Verheij
Maarten F Schim van der Loeff
Neeltje Kootstra
Marc van der Valk
Peter Reiss
AGEhIV Cohort Study Group
Generally rare but occasionally severe weight gain after switching to an integrase inhibitor in virally suppressed AGEhIV cohort participants.
PLoS ONE
title Generally rare but occasionally severe weight gain after switching to an integrase inhibitor in virally suppressed AGEhIV cohort participants.
title_full Generally rare but occasionally severe weight gain after switching to an integrase inhibitor in virally suppressed AGEhIV cohort participants.
title_fullStr Generally rare but occasionally severe weight gain after switching to an integrase inhibitor in virally suppressed AGEhIV cohort participants.
title_full_unstemmed Generally rare but occasionally severe weight gain after switching to an integrase inhibitor in virally suppressed AGEhIV cohort participants.
title_short Generally rare but occasionally severe weight gain after switching to an integrase inhibitor in virally suppressed AGEhIV cohort participants.
title_sort generally rare but occasionally severe weight gain after switching to an integrase inhibitor in virally suppressed agehiv cohort participants
url https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0251205&type=printable
work_keys_str_mv AT sebastiaanoverboeket generallyrarebutoccasionallysevereweightgainafterswitchingtoanintegraseinhibitorinvirallysuppressedagehivcohortparticipants
AT andersboyd generallyrarebutoccasionallysevereweightgainafterswitchingtoanintegraseinhibitorinvirallysuppressedagehivcohortparticipants
AT ferdinandwwit generallyrarebutoccasionallysevereweightgainafterswitchingtoanintegraseinhibitorinvirallysuppressedagehivcohortparticipants
AT evelineverheij generallyrarebutoccasionallysevereweightgainafterswitchingtoanintegraseinhibitorinvirallysuppressedagehivcohortparticipants
AT maartenfschimvanderloeff generallyrarebutoccasionallysevereweightgainafterswitchingtoanintegraseinhibitorinvirallysuppressedagehivcohortparticipants
AT neeltjekootstra generallyrarebutoccasionallysevereweightgainafterswitchingtoanintegraseinhibitorinvirallysuppressedagehivcohortparticipants
AT marcvandervalk generallyrarebutoccasionallysevereweightgainafterswitchingtoanintegraseinhibitorinvirallysuppressedagehivcohortparticipants
AT peterreiss generallyrarebutoccasionallysevereweightgainafterswitchingtoanintegraseinhibitorinvirallysuppressedagehivcohortparticipants
AT agehivcohortstudygroup generallyrarebutoccasionallysevereweightgainafterswitchingtoanintegraseinhibitorinvirallysuppressedagehivcohortparticipants